Latest Blog Posts Tagged "Carbidopa-levodopa (Sinemet)"
February 13, 2019
Listen to Dr. Rachel Dolhun tackle widespread myths about levodopa.
February 07, 2019
Levodopa is the most effective Parkinson's medication, but there are many misconceptions about what this drug can and can't do. In this video, Dr. Dolhun discusses the facts about levodopa.
January 25, 2019
New research on levodopa, the most commonly prescribed Parkinson's medication, confirms that the drug neither speeds nor delays disease progression.
July 02, 2018
Dr. Arvid Carlsson -- who linked Parkinson's disease to dopamine loss and discovered the effects of levodopa treatment -- has died.
December 08, 2016
Voyager Therapeutics announced results from a trial, supported in early stages by MJFF, to help the brain convert levodopa to dopamine and better control motor symptoms.
December 28, 2015
Adamas has announced positive Phase III results for its treatment for dyskinesia, involuntary movements that are a side effect of levodopa use. Such a therapy could impact how we treat motor symptoms.
May 06, 2015
Dr. Rachel Dolhun tells Practical Neurology about recently approved levodopa formulations that may help avoid wearing off and dyskinesia.
March 29, 2015
Rytary, an extended-release formuation of levodopa/carbidopa, will soon be available for prescription. The treatment requires more pills but comes with less dyskinesia.
January 12, 2015
Today pharmaceutical company AbbVie announced it has obtained approval for Duopa, its gel formulation of levodopa/carbidopa infused directly into the small intestine.
January 08, 2015
Today MJFF-awardee Impax Pharmaceuticals announced that the FDA approved RYTARY, an extended-release oral capsule formulation of levodopa-carbidopa, for the treatment of Parkinson's.